These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 388295)

  • 1. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients.
    Johansson F; Von Knorring L
    Pain; 1979 Aug; 7(1):69-78. PubMed ID: 388295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zimelidine: a therapeutic and pharmacokinetic study in depression.
    Coppen A; Ramo Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 Jun; 63(3):199-202. PubMed ID: 113803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor.
    Aberg A; Holmberg G
    Acta Psychiatr Scand; 1979 Jan; 59(1):45-58. PubMed ID: 369299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine.
    von Knorring L; Johansson F
    Neuropsychobiology; 1980; 6(6):313-8. PubMed ID: 6449679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain.
    Gourlay GK; Cherry DA; Cousins MJ; Love BL; Graham JR; McLachlan MO
    Pain; 1986 Apr; 25(1):35-52. PubMed ID: 2940499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.
    Koczkas S; Holmberg G; Wedin L
    Acta Psychiatr Scand Suppl; 1981; 290():328-41. PubMed ID: 6452799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zimelidine, a selective 5-HT uptake inhibitor, on serum prolactin levels in man.
    Syvälahti E; Nagy A; van Praag HM
    Psychopharmacology (Berl); 1979 Sep; 64(3):251-3. PubMed ID: 116266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
    Coppen A; Rama Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 May; 63(2):125-9. PubMed ID: 112630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial.
    Hanna MH; Peat SJ
    Pain; 1989 Aug; 38(2):145-50. PubMed ID: 2780070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients.
    Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
    Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
    Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
    Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.